References
- Carretero, O. A., Oparil, S., Circulation. Essential Hypertension : Part I : Definition and Etiology. 2000, Circulation, 101, 329–335.
- 李星勳, 全燦鎔, 朴鐘榮, 腦卒中患者 226例에 對한 臨床的 考察, 大韓韓醫學會誌 1997, 18(1) : 5–24.
- 서울대학교 의과대학, 심장학, 서울, 서울대학교 출판부, 1987, pp. 207-211.
- Gross, F., Robertson, J. I. S., Arterial Hypertension. G. K. Hall & Co., 1980, 5 : 1–6.
- Levi, R., Therapies for perioperative hypertension : Pharmacodynamic considerations, Acta Anaesthesiol. Scand. Suppl., 1993, 37(99) 16–19.
- 金完熙, 高血壓治療의 辨證에 關한 硏究. 大韓韓醫學會誌 1982, 3(2) : 3–13.
- 楊維傑, 黃帝內經素問譯解, 서울, 成輔社, 1980, p. 96, 633, 662, 663.
- 張隱庵, 黃帝內經素問集注, 上海, 上海科學技術出版社, 1991. p. 4.
- 黃度淵, 對譯證脈方藥合編, 南山堂, 서울, 1985, pp. 232-233.
- 許浚, 東醫寶鑑, 法人文化社, 서울, 2002, p. 501.
- 李尙仁, 本草學, 圖書出版 修書院, 서울, 1981, pp.192-193, 195-196, 198-202, 207-208, 221-222, 228-231, 481-483, 501-509.
- 송효정, 문준전, 청상사화탕이 혈압 및 지질대사에 미치는 영향, 경희대논문집 1982, 5 : 131-146.
- 何紹奇, 現代中醫內科學, 北京, 中國醫藥科技出版社, 1991, pp. 263-268.
- 金完熙, 崔達永, 臟腑辨證論治, 서울, 成輔社, 1985, p. 139, 140.
- Vanhoutte, P. M., Houston, D. S., Platelets and vascular occlusion, Platelets, endothelium, and vasospasm, Circulation 1985 ; 72(4) : 728–734.
- Vanhoutte, P. M., Rubanyi, G. M., Miller, V. M., Houston D. S., Modulation of vascular smooth muscle contraction by the endothelium. Ann. Rev. Physiol., 1986 ; 48 : 307–320. https://doi.org/10.1146/annurev.ph.48.030186.001515
- Feletou, M., Vanhoutte, P. M., Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol., 1988 ; 93 : 515–524.
- Suzuki, H., Chen, G., Yamamoto, Y., Miwa, K., Nitroarginine-sensitive and -insensitive components of the endothelium-dependent relaxation in the guinea-pig carotid artery. Jpn. J. Physiol., 1992 ; 42(2) : 335–347.
- Feletou, M., Girard, V., Canet, E., Different Involvement of Nitro Oxide in Endothelium-Dependent Relaxation of Porcine Pulmonary Artery and Vein : Influence of Hypoxia. J. of Cardiovascular Pharmacology, 1995 ; 25 : 665–673.
- Hecker, M., Endothelium-derived hyperpolarzing factor - fact or fiction?. News Physiol. Sci., 2000 ; 15 : 1–5.
- Yokota, Y., Imaizumi, Y., Ansano, M., Matsuda, T., Watanabe, M., Endothelium-derived relaxing factor releaved by 5-HT : distinct from nitric oxide in basilar arteries of normotensive and hypertensive rats. Br. J. Pharmacol., 1994 ; 11 : 24–330.
- Johns, R. A., Endothelium-derived relaxing factor ; Basic review and clinical implications. J. Cardiothorac. Vasc. Anesth., 1991 ; 5(1) : 69–79.
- Palmer, R. M. J., Ferrige, A. G., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 1987 ; 327 : 524–526. https://doi.org/10.1038/327524a0
- Palmer, R. M., Rees, D. D., Ashton, D. S., Moncada, S., L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 1988 ; 153(3) : 1251–1256. https://doi.org/10.1016/S0006-291X(88)81362-7
-
Moore, P. K., al-Swayeh, O. A., Chong N. W. S., Evans R. A., Gibson A.,
$_L-N^G$ -nitro arginine$(_L-NOARG)$ , a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br. J. Pharmacol., 1990 ; 99 : 408–412. - Nandor, M., Una, S. R., John, D. C., Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture. Am. J. Physiol., 1992 ; 263 : L113–L121.